Transcode Therapeutics Inc (RNAZ) — Cash Flow Quality Index

Latest as of June 2021: -0.06x

Transcode Therapeutics Inc (RNAZ) has a Cash Flow Quality Index of -0.06x as of June 2021. Operating cash flow of $-161.66K is below net income of $2.77 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Transcode Therapeutics Inc (RNAZ) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.06x

Operating CF / Net Income

Operating Cash Flow

$-161.66K

USD

Net Income

$2.77 Million

USD

Data as of

Jun 2021

Most recent filing

Annual Cash Flow Quality Index for Transcode Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Transcode Therapeutics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.